The UK’s Competition and Markets Authority (CMA) announced on Wednesday that it may accept the remedies proposed by Synopsys and Ansys to resolve concerns about their $35 billion merger. The deal, which was announced in January last year, involves Synopsys acquiring Ansys, a company known for its software used in industries ranging from aerospace to sports equipment.
The CMA stated that the remedies, offered on December 31, involve the divestment of certain products: Ansys will sell its power consumption analysis product for digital chips, and Synopsys will divest its global optics and photonics software business.
The watchdog now has until March 5 to decide whether to approve these remedies, with the option to extend the deadline until May 6. A Synopsys spokesperson expressed satisfaction with the CMA’s decision, emphasizing that the companies are committed to maintaining a “constructive and collaborative engagement” with the regulator.
